Point Of Care Infectious Disease Market - Forecast(2021 - 2026)

Report Code: HCR 96604 Report Format: PDF + Excel (Delivery in 48 Hrs)

Point of Care Infectious Disease Market Overview

Point of Care Infectious Disease Market size was estimated at $1.9 billion in 2020, projected to grow at a CAGR of 12.3% during the forecast period 2021-2026. Point of Care Infectious Disease industry has witnessed huge demand owing to the rising cases of infectious diseases caused by pathogenic microorganisms. Clostridium difficile, human papillomavirus, Mycobacterium tuberculosis are some of the infectious diseases that are transmitted through individuals and populations, thus impacting human and economic health as a whole. Lateral flow immunoassay (LFA) is the most common diagnostic method that meets the standards of colorimetric assay. It is used as a POC (point of Care) test to diagnose infectious diseases. To provide precise and timely guidance for case identification, effective diagnostic tools are required. Point of care tests provides the patient with actionable data, and serve as a personal radar.

In order to achieve patient care goals, the evolving space for point of care instruments is significantly advancing. The launch of handheld devices and self-testing devices has increased the access to testing and tracking services to the remote places where emergency treatment is a challenge. The growing prevalence rate of infectious diseases along with rising geriatric population contribute to boost the demand for better diagnostics in the market.

Point of Care Infectious Disease Market Report Coverage

The report: “Point of Care Infectious Disease Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Point of Care Infectious Disease Market.
By Disease: Clostridium Difficile Infections (CDI), Tuberculosis, Human Papillomavirus, HIV, Hepatitis B Virus, Pneumonia, Influenza, Hepatitis C Virus and others.
By Technique: Lateral Flow Immunoassay, Flow-through Test, Agglutination Test, Molecular Diagnostics and Others
By End User: Hospitals, Clinics, Nursing Homes, Home & Self-testing and others 
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America), and Rest of the World (Middle East and Africa)

Key Takeaways

  • Geographically, North America Point of Care Infectious Disease Market held the largest revenue share of 41% in 2020 owing to the well-developed healthcare infrastructure and growing prevalence of infectious disease in this region.
  • Rise in the R&D activities by the key players of the market in both diagnostic and therapeutic areas of infectious diseases is set to propel the industry growth.
  • Increase in FDA approvals for innovative diagnostic technologies are now rapidly delivering innovations in the Point of Care Infectious Disease Market.
  • The development of rapid RT_PCR tests for diagnosing influenza for better detection of infection causing microorganism than the traditional tests are projected to fuel the market growth.

Point of Care Infectious Disease Market – Market Share (%) by Disease, 2020

Point of Care Infectious Disease Market
For More Details on This Report - Request for Sample

Point of Care Infectious Disease Market Segment Analysis – By Disease:

Based on Disease, Point of Care Infectious Disease Market is segmented into Clostridium Difficile Infections (CDI), Tuberculosis (TB), Human Papillomavirus, HIV, Hepatitis B Virus, Pneumonia, Influenza, Hepatitis C Virus and others. Clostridium Difficile Infections has accounted for the largest revenue market share in 2020 owing to huge volume of sales of POC kits for its diagnosis of CDI. CDI is often termed as C.difficile or C.diff. It is a bacteria that causes symptoms from diarrhea to inflammation in colon that sometimes become life threatening. CDI affects the old people most often in hospitals or in long-term care centers and mostly happens after use of antibiotic medications. However, studies show that the rate of CDI are growing in those who are not typically at high risk, such as young and active people that have not used antibiotics, and the ones who haven’t been in a healthcare facility. In the U.S., around 500,000 people become ill each year from CDI, and CDI diseases have increased and became severe and challenging to treat. Moreover, recurrent of CDI are also in the rise. Owing to the increasing prevalence of diseases like TB and growing demand for POC testing of Influenza, TB is estimated to grow with the fastest CAGR of 12.6% in the forecast period 2021-2026. 

Point of Care Infectious Disease Market Segment Analysis – By Technique:

Based on Technique, Point of Care Infectious Disease Market is segmented Lateral Flow Immunoassay, Flow-through Test, Agglutination Test, Molecular Diagnostics. The lateral flow immunoassay (LFA) has held a dominant market share in 2020 owing to the faster diagnosis and the availability of test kits in decentralised settings. The molecular diagnostics segment is anticipated to grow with fastest CAGR of 12.5% during the forecast period 2021-2026 owing to the growing applications of ELISA, RT-PCR, and others in the infectious diseases point of care testing kits. Moreover, the rise in FDA approvals in this segment is boosting the sales of this segment.

Point of Care Infectious Disease Market Segment Analysis – By Geography:

Based on Geography, North America Point of Care Infectious Disease Market accounted for the 41% revenue share in 2020. This is majorly attributed to the technological advancements, and growing infectious diseases in this region. According to studies, each year 9% of population in the U.S. are affected by infectious diseases. According to Center for Disease Control and Prevention, in the year 2019, around 8,920 cases of Tuberculosis were reported in the United States. Asia-Pacific is projected to grow with the fastest CAGR in the forecast period 2021-2026 owing to the growing R&D expenditure in patient-centric facilities in China & Japan. For instance, in May 2017, One BioMed and A Star’s Genome Institute of Singapore has come under a joint venture for production of molecular diagnostic assay. In addition, the drastically increasing prevalence of infectious diseases. For instance, the prevalence of Human papillomavirus (HPV) is around 15.6% in women with normal cervical cytology in China. The prevalence of HPV is higher in central China it is around 20.5%. In addition, the presence of various government policies to promote early diagnosis are the factors poised to boost the market in this region.

Point of Care Infectious Disease Market Drivers

Rising Prevalence of Infectious Diseases:

The growing prevalence of infectious diseases like TB, Influenza, HIV, RSV lead to an increase in the rate of diagnostics of patients. For instance, in 2019 according to the United Nations Program on HIV/AIDS (UNAIDS), round 38 million were tested positive for HIV/AIDS. According to the WHO, in 2018, approximately 10 million were affected by TB worldwide. Therefore, the increasing infection rate of various diseases globally leads to growth in uptake of POC kits for its diagnosis and aid to the growth of the market. 

Point of Care Infectious Disease Market Challenges

Lack of Accuracy with POC Diagnostic Tests:

Emerging countries accounts for the major portion of global population with high prevalence of infectious diseases such as HIV, malaria, TB. Lack of training for lab technicians and lack of proper lab infrastructure and accessibility owing to the lower per capita income of these low-middle income countries has led to decreased adoption of the Point of Care kits. According to a published article of National Center for Biotechnology Information (NCBI) in the year 2019, within the survey of 420 clinician respondents of Africa, approximately more than 30% of clinicians were reported to lack proper training to perform a POC diagnostic test. Thereby resulting in the misinterpretation of results and affecting the accuracy rate of the tests and hampering the market growth.

Point of Care Infectious Disease Market Segment Landscape:

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Point of Care Infectious Disease Market. Point of Care Infectious Disease Market top 10 companies are Ortho-Clinical Diagnostics, Alere, Trinity Biotech, Thermo Fisher Scientific, Inc., Cardinal Health, Siemens Healthineers, Quest Diagnostics, Inc., Gene POC, Sight Diagnostics Ltd., BioMerieux SA.

Acquisitions/Product Launches:

  • In June 2020, Cepheid has announced to launch its four in one combination test Xpert Xpress SARS-CoV-2/Flu/RSV to detect RSV, Flu A, SARS-CoV-2, and Flu B from a sample of a single patient.

Related Reports:

Report Code: HCR 0085

Report Code: HCR 75469

For more Lifesciences and Healthcare Market reports, please click here
1. Point of Care Infectious Disease Market - Overview
    1.1 Definitions and Scope
2. Point of Care Infectious Disease Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Disease
    2.3 Key trends by Technique
    2.4 Key trends by End User
    2.5 Key trends by Geography
3. Point of Care Infectious Disease Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split - Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis – Average Selling Price
4. Point of Care Infectious Disease Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Point of Care Infectious Disease Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Point of Care Infectious Disease Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Point of Care Infectious Disease Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Point of Care Infectious Disease Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Clostridium Difficile Infections (CDI)
    8.2 Tuberculosis
    8.3 Human Papillomavirus
    8.4 HIV
    8.5 Hepatitis B Virus
    8.6 Pneumonia
    8.7 Influenza
    8.8 Hepatitis C Virus
    8.9 Others
9. Point of Care Infectious Disease Market – By Technique (Market Size –$Million/$Billion)
    9.1 Lateral Flow Immunoassay
    9.2 Flow-through test
    9.3 Agglutination Test
    9.4 Molecular Diagnostics
    9.5 Others
10. Point of Care Infectious Disease Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Clinics
    10.3 Nursing Homes
    10.4 Home & Self-testing
    10.5 Others
11. Point of Care Infectious Disease Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Point of Care Infectious Disease Market - Entropy
13. Point of Care Infectious Disease Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Point of Care Infectious Disease Market – Key Company List by Country Premium Premium
15. Point of Care Infectious Disease Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
1.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Global Industry Research
1.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Global Industry Research
2.Global GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
2.1 HOSPITALS Market 2019-2024 ($M) - Global Industry Research
2.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Global Industry Research
2.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Global Industry Research
2.4 SURGERY CENTRES Market 2019-2024 ($M) - Global Industry Research
2.5 BIRTH CENTRES Market 2019-2024 ($M) - Global Industry Research
3.Global GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 (Volume/Units)
3.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 (Volume/Units)
4.1 HOSPITALS Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 EMERGENCY ROOMS Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 AMBULATORY CARE CENTRES Market 2019-2024 (Volume/Units) - Global Industry Research
4.4 SURGERY CENTRES Market 2019-2024 (Volume/Units) - Global Industry Research
4.5 BIRTH CENTRES Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
5.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
5.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
6.North America GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
6.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
6.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Regional Industry Research
6.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Regional Industry Research
6.4 SURGERY CENTRES Market 2019-2024 ($M) - Regional Industry Research
6.5 BIRTH CENTRES Market 2019-2024 ($M) - Regional Industry Research
7.South America GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
7.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
7.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
8.South America GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
8.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
8.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Regional Industry Research
8.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Regional Industry Research
8.4 SURGERY CENTRES Market 2019-2024 ($M) - Regional Industry Research
8.5 BIRTH CENTRES Market 2019-2024 ($M) - Regional Industry Research
9.Europe GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
9.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
9.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
10.Europe GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
10.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
10.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Regional Industry Research
10.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Regional Industry Research
10.4 SURGERY CENTRES Market 2019-2024 ($M) - Regional Industry Research
10.5 BIRTH CENTRES Market 2019-2024 ($M) - Regional Industry Research
11.APAC GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
11.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
11.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
12.APAC GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
12.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
12.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Regional Industry Research
12.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Regional Industry Research
12.4 SURGERY CENTRES Market 2019-2024 ($M) - Regional Industry Research
12.5 BIRTH CENTRES Market 2019-2024 ($M) - Regional Industry Research
13.MENA GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY METHODS Market 2019-2024 ($M)
13.1 ANTIBODY BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
13.2 MICROBIAL PARTICLE BASED DIAGNOSTICS Market 2019-2024 ($M) - Regional Industry Research
14.MENA GLOBAL POINT OF CARE INFECTIOUS DISEASE MARKET, BY END USERS Market 2019-2024 ($M)
14.1 HOSPITALS Market 2019-2024 ($M) - Regional Industry Research
14.2 EMERGENCY ROOMS Market 2019-2024 ($M) - Regional Industry Research
14.3 AMBULATORY CARE CENTRES Market 2019-2024 ($M) - Regional Industry Research
14.4 SURGERY CENTRES Market 2019-2024 ($M) - Regional Industry Research
14.5 BIRTH CENTRES Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
2.Canada Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
3.Mexico Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
4.Brazil Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
5.Argentina Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
6.Peru Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
7.Colombia Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
8.Chile Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
9.Rest of South America Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
10.UK Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
11.Germany Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
12.France Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
13.Italy Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
14.Spain Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
15.Rest of Europe Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
16.China Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
17.India Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
18.Japan Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
19.South Korea Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
20.South Africa Point Of Care Infectious Disease Market Revenue, 2019-2024 ($M)
21.North America Point Of Care Infectious Disease By Application
22.South America Point Of Care Infectious Disease By Application
23.Europe Point Of Care Infectious Disease By Application
24.APAC Point Of Care Infectious Disease By Application
25.MENA Point Of Care Infectious Disease By Application
26.DIASORIN S.P.A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.F. HOFFMANN LA ROCHE LTD, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.THERMOFISCHER SCIENTIFIC INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.SERACARE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.BIO-RAD LABORATORIES INC, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.HOLOGIC INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.ALERE, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.ENZO BIOCHEM INC., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.BECTON, DICKENSON AND COMPANY, Sales /Revenue, 2015-2018 ($Mn/$Bn)